Upcoming Biologics Events

Biotherapeutics US: Online

17 - 18 November 2021 |

EST (UTC-5)

17 - 18 November 2021

EST (UTC-5)

Accelerating The Development Of Biotherapeutics Through Exploring Different Modalities, Breakthrough Technologies And Analytical Methods

Biologics UK: In-Person

21 - 22 March 2022 |

London, UK

21 - 22 March 2022

London, UK

+ Digital Day: 22 March 2022 | Online

More Information Coming Soon

Oligonucleotides Chemistry & Therapeutics Symposium

12 May 2022 |

Online: BST (UTC+1)

12 May 2022

Online: BST (UTC+1)

An intensive 1-day meeting that delves into the latest developments in oligonucleotide synthesis, chemistry, process & analytical development, and therapeutics

More Information Coming Soon

Antibody Engineering: Online

27 - 28 June 2022 |

BST (UTC+1)

27 - 28 June 2022

BST (UTC+1)

More Information Coming Soon

Peptides Synthesis Design Symposium

06 October 2022 |

Online: BST (UTC+1)

06 October 2022

Online: BST (UTC+1)

More Information Coming Soon

Biotherapeutics Analysis US: Online

29 November 2022 |

EST (UTC-5)

29 November 2022

EST (UTC-5)

More Information Coming Soon

Upcoming Discussion Groups

Our monthly Discussion Groups are hosted by a panel of leading industry experts who explore some of the key issues facing biologics therapeutics today.

Register below to receive a live stream of the discussion as well a complimentary report outlining the key findings and conclusions covered.

Antibody Discovery, Optimisation & Engineering

24 Sept 2021 | Online: 10:00 ET (UTC-4) / 15:00 BST (UTC+1)

With the recent advancements of antibody engineering technologies, techniques and methods, the market has seen an expansion. This growth is largely attributed to our better understanding of new modalities, smarter ways of choosing our targets and ensuring their quality, though challenges still remain. Our September discussion groups brings together an exclusive panel of key opinion leaders discussing the key factors behind the market’s growth, its priorities, future outlook & challenges.

Presentation: Antibody Discovery At Novo Nordisk

  • Complementary technical approaches
  • Current initiatives to develop better antibodies faster

     

Speaker: Erik Vernet, Director, Antibody technology, Novo Nordisk

Panel Discussion: Oral Delivery of Biologics – Current Challenges & Opportunities

  • Discovery strategy: in vivo and in vitro
  • Multi parameter developability
  • Display technologies – what are the current trends in the industry?
  • Incorporating ML/AI into the discovery pipeline
  • Hybridoma platform – Does it still have its place?

Moderator: Erik Vernet, Director, Antibody Technology, Novo Nordisk

Panellists:

  • William Olson, Senior Vice President, Therapeutic Peptides, Regeneron
  • Rick Davies, Senior Director of Chemical Biology and Protein Science, AstraZeneca
  • Jonathan Davis, Vice President of Innovation & Strategy, Invenra 
Biotherapeutics Analytics & Development

Taking place October 2021

Viewer Registration Coming Soon

Bispecific & Multi Specific Antibodies and Therapeutics

Taking place November 2021

Viewer Registration Coming Soon

Reports and write-ups pertaining to previous Discussion Groups are available in our Insights section.

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Download Series Agenda at a Glance

Submit your details to register your interest & to be kept up to date about relevant services or events. You may opt-out at any time. Please check our Privacy Policy to see how Oxford Global protects and manages your data.

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Biologics

Submit your details to receive the monthly newsletter & to be kept up to date about relevant events, monthly discussion groups and portal membership offers. You may opt-out at any time. Please check our Privacy Policy to see how Oxford Global protects and manages your data.